ContraFect Corp (NASDAQ:CFRX)

3.96
BATS BZX Real-Time Price
As of 11:36am ET
 -0.15 / -3.65%
Today’s Change
3.44
Today|||52-Week Range
8.00
-21.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$162.4M

Company Description

ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.

Contact Information

ContraFect Corp.
28 Wells Avenue
Yonkers New York 10701
P:(914) 207-2300
Investor Relations:

Employees

Shareholders

Other institutional36.57%
Mutual fund holders28.00%
Individual stakeholders0.32%

Top Executives

Roger J. PomerantzChairman, President & Chief Executive Officer
Michael MessingerChief Financial Officer
Cara CassinoChief Medical Officer & EVP-Research & Development
Raymond SchuchVice President-Research
Bogdanos NatalieSecretary & General Counsel